Table 4 Risk factors from Logistic Regression unique to 0, 12 and 24 week(s)
From: Analysis of risk factors progression of preterm delivery using electronic health records
| Â | Code | Description | Risk Ratios(95% CI) |
|---|---|---|---|
0 week | M_409672909.0 | Magnesium Sulfate, Injectable/magnesium sulfate | 1.68(1.49-1.87) |
| Â | L_26464-8 | White Blood Cell Count, Blood | 1.75(1.54-1.96) |
| Â | D_654.20 | Previous Cesarean Section, Unspecified as to Episode of Care or Not Applicable | 1.59(1.46-1.72) |
| Â | L_32766-8 | Trichomonas vaginalis | 1.57(1.43-1.71) |
| Â | M_409672903.0 | Magnesium Sulfate, Injectable/magnesium sulfate | 1.57(1.42-1.71) |
| Â | D_V12.09 | Other Personal History of Infectious and Parasitic Disease | 1.54(1.37-1.7) |
| Â | M_55390012110.0 | Ondansetron Hydrochloride/ondansetron | 1.51(1.34-1.68) |
| Â | D_V15.81 | Personal History of Noncompliance with Medical Treatment, Presenting Hazards to Health | 1.47(1.32-1.62) |
| Â | D_644.20 | Early Onset of Delivery, Unspecified as to Episode of Care or Not Applicable | 1.46(1.31-1.61) |
| Â | L_741-9 | Differential Microcytes | 1.41(1.28-1.53) |
| Â | L_10378-8 | Polychromasia Qualitative Blood Light Microscopy | 1.41(1.27-1.54) |
| Â | D_645.11 | Post Term Pregnancy, Delivered, with or without Mention of Antepartum Condition | 0.49(0.35-0.63) |
12 weeks | D_O30.041 | Twin pregnancy, dichorionic/diamniotic, first trimester | 1.65(1.62-1.69) |
| Â | D_O34.219 | Maternal care for unspecified type scar from previous cesarean delivery | 1.57(1.39-1.75) |
24 weeks | D_O09.91 | Supervision of high risk pregnancy, unspecified, first trimester | 1.7(1.53-1.86) |
| Â | M_51079092920.0 | Labetolol Hydrochloride/labetalol | 1.73(1.58-1.87) |
| Â | D_O30.009 | Twin pregnancy unspecified number of placenta and unspecified number of amniotic sacs unspecified trimester | 1.45(1.39-1.51) |